Key Financial Data Of Group

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7312808

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
Key financial data of group
Business results of group
Net sales
73,136,000,000 JPY
173,455,000,000 JPY
73,625,000,000 JPY
Ordinary profit (loss)
10,434,000,000 JPY
27,330,000,000 JPY
11,174,000,000 JPY
Profit (loss) attributable to owners of parent
1,436,000,000 JPY
20,338,000,000 JPY
7,864,000,000 JPY
Comprehensive income
9,078,000,000 JPY
25,957,000,000 JPY
14,549,000,000 JPY
Net assets
209,734,000,000 JPY
204,816,000,000 JPY
208,591,000,000 JPY
Total assets
262,254,000,000 JPY
267,473,000,000 JPY
266,573,000,000 JPY
Basic earnings (loss) per share
19.32
268.16
103.35
Diluted earnings per share
Equity-to-asset ratio
0.797 xbrli:pure
0.764 xbrli:pure
0.781 xbrli:pure
Net cash provided by (used in) operating activities
5,522,000,000 JPY
18,360,000,000 JPY
7,246,000,000 JPY
Net cash provided by (used in) investing activities
-14,879,000,000 JPY
-19,576,000,000 JPY
-8,083,000,000 JPY
Net cash provided by (used in) financing activities
-4,438,000,000 JPY
-19,463,000,000 JPY
-4,061,000,000 JPY
Cash and cash equivalents
47,172,000,000 JPY
59,690,000,000 JPY
75,586,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.